As such, investors all around may want to keep an eye on biotech stocks. Earlier this week, Novavax (NASDAQ: NVAX) received some positive news regarding its vaccine in India. Namely, the company ...

The company had planned to sell 13.6 million shares in the range of $28 to $31 apiece. The IPO haul was about $500 million. The biotech’s shares will trade on the Nasdaq under the stock symbol ...

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism ...

Traders have been choosing to avoid biotech stocks amid macroeconomic ... And the company has seemingly interesting technology and an appealing ticker symbol. On closer inspection, however ...

Strive Asset Management has raised $750 million to pursue the strategy while Ramaswamy runs to be Ohio’s governor.

Morningstar brands and products Company Portfolio ...

CEN Biotech, Inc. focuses on the manufacture ... and to provide digital marketing and web design related services. The company was incorporated in 2013 and is based in Windsor, Canada.

The idea is a biotech stock might soar as investors bet on the company's cutting-edge technology through its development stages -- and the stock could continue to gain after that company moves ...